SEC Company Response from Predictive Oncology Inc. (AGPU) (CIK 0001446159) (AGPU) — Apr 1, 2016
Predictive Oncology Inc. (AGPU) (CIK 0001446159)
Date: April 1, 2016 · CIK: 0001446159 · Accession: 0001171843-16-008962
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-210398
Letter
April 1, 2016
Skyline Medical Inc.
2915 Commers Drive, Suite 900
Eagan, Minnesota 55121
BY EDGAR
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attention: Mr. Brian Soares
Re: Skyline Medical Inc. Registration
Statement on Form S-4
File No. 333-210398
Request for Acceleration
Ladies and Gentlemen:
In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Skyline Medical Inc., a Delaware corporation (the “Registrant”), hereby requests that the effectiveness of the above-referenced Registration Statement on Form S-4 (the “Registration Statement”), be accelerated so that it will be declared effective at 9:00 a.m. Eastern time on April 5, 2016, or as soon thereafter as practicable.
The Registrant hereby acknowledges that:
(i) should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;
(ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and
(iii) the Registrant may not assert staff comments and the declaration of the effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
[Signature page follows]
Very truly yours,
Skyline Medical Inc.
Show Raw Text
CORRESP
1
filename1.htm
April 1, 2016
Skyline Medical Inc.
2915 Commers Drive, Suite 900
Eagan, Minnesota 55121
BY EDGAR
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attention: Mr. Brian Soares
Re: Skyline Medical Inc.
Registration
Statement on Form S-4
File No. 333-210398
Request for Acceleration
Ladies and Gentlemen:
In accordance with Rule 461 of the General Rules and Regulations
under the Securities Act of 1933, as amended, Skyline Medical Inc., a Delaware corporation (the “Registrant”),
hereby requests that the effectiveness of the above-referenced Registration Statement on Form S-4 (the “Registration Statement”),
be accelerated so that it will be declared effective at 9:00 a.m. Eastern time on April 5, 2016, or as soon thereafter as practicable.
The Registrant hereby acknowledges that:
(i)
should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated
authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect
to the Registration Statement;
(ii)
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement
effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the
Registration Statement; and
(iii)
the Registrant may not assert staff comments and the declaration of the effectiveness as a defense in any proceeding initiated
by the Commission or any person under the federal securities laws of the United States.
[Signature page follows]
Very truly yours,
Skyline Medical Inc.
By: /s/ Joshua Kornberg
Name: Joshua Kornberg
Title: Chief Executive Officer